Opportunity

Alberta Purchasing #AB-2026-00570

Direct Award for CEDIA™ and DRI™ Reagents and Consumables to Diagnostix Ltd (Thermo Fisher Scientific)

Posted

January 22, 2026

Identifier

AB-2026-00570

NAICS

424210, 325413

This award notice details the direct procurement of specialized laboratory reagents and consumables for toxicology testing at the University of Calgary's Alberta Centre for Toxicology (ACFT): - Government Buyer: - University of Calgary, Alberta Centre for Toxicology (ACFT) - Supporting Alberta Health Services Opioid Dependency Program - OEMs and Vendors: - Thermo Fisher Scientific (OEM) - Diagnostix Ltd (subsidiary/distributor of Thermo Fisher Scientific) - Products/Services Requested: - CEDIA™ and DRI™ reagents, calibrators, and controls - Used for urine drug testing - No specific part numbers or quantities provided - Unique/Notable Requirements: - Direct award to ensure compatibility and standardization with existing laboratory systems (DxC 500 AU and Olympus AU480 instruments) - Only Diagnostix's (Thermo Fisher Scientific) products meet the operational and research requirements of ACFT - Focus on maintaining validated testing protocols and instrument compatibility

Description

The University of Calgary requires the purchase of CEDIA and DRI reagents, calibrators, and controls from Diagnostix Ltd, a Thermo Fisher Scientific company. These reagents are used by the Alberta Centre for Toxicology to conduct urine drug testing supporting the Alberta Health Services Opioid Dependency Program. The procurement ensures standardization and compatibility with existing laboratory systems and instruments, avoiding validation issues, downtime, and additional costs. Diagnostix's reagents and consumables are understood to be the only products meeting the research and operational requirements.

View original listing